We are celebrating 24 years in Business - Thank You For Making Us The #1 Go To Site for Your Health Care

hematology, medical oncology, oncology review course, board review, recalled oncology questions, breast cancer, radiation, bone, cervix, breast, lymphoma, oncology, pediatrics, breast surgery, colon, hydrotherapy, prostate, prostate cancer, oncology board review questions, bladder, bone tumors, bladder, wilms tumor, hematology, colon, testicular, radiation therapy, radiation treatment, colon cancer, skin, carcinoma, endometrium, bone marrow, bone cancer, tumors, radiation, bone tissue, breast cancer, skin diseases, gynecology, rhabdo, myosarcoma, whole body radiation, hyperfractionation, head neck, thymomas, mediastinal masses, cns tumors, esophagus, renal carcinoma, desmoid tumor of the abdominal wall, neuro, radiation oncology, google, comprehensive board review, devita, hellman, rosenbergs cancer, e-book, e-books, Amazon Kindle, Palm, mobipocket, pda books, PDF, Iliad, DRM-free, Palm DOC, RTF, EPUB

Medical-technology-news

The latest cancer news for cancer research. Inform yourselves about the newest technologies, best practices and studies in the field of cancer diseases and tumors.

  • Physics tool helps track cancer cell diversity February 20, 2020
    A team took a novel, interdisciplinary approach to analyzing the behavior of breast tumor cells by employing a statistical modeling technique more commonly used in physics and economics. The team was able to demonstrate how the diversity, or heterogeneity, of cancer cells can be influenced by their chemical environment -- namely, by interactions with a speci […]
  • Origins of immune system mapped, opening doors for new cancer immunotherapies February 20, 2020
    A first cell atlas of the human thymus gland could lead to new immune therapies to treat cancer and autoimmune diseases. Researchers mapped thymus tissue through the human lifespan to understand how it develops and makes vital immune cells called T cells. In the future, this information could help researchers to generate an artificial thymus and engineer imp […]
  • New front opened in fight against common cancer driver February 20, 2020
    Researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells. The team hopes that this could be a new target for treating a range of cancers.
  • A deep dive into cellular aging February 20, 2020
    Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus --a nd identified an FDA-approved drug that helped suppress the damaging effects of the condition in cells and mice. The discovery could lead to treatments that promote healthy aging or prevent age-associated […]
  • CRISPR enhances production of EPO used to treat anemia February 19, 2020
    EPO, an important drug for treating anemia, can now be produced in higher quantities and with better quality in mammalian cells designed using CRISPR.
  • Targeting turncoat immune cells to treat cancer February 18, 2020
    A new study has identified a mechanism by which regulatory T cells, which suppress immune responses, adapt their metabolism to thrive in the harsh microenvironment of the tumor.
  • New areas in human genomes linked to skin cancer risk February 18, 2020
    A cancer researcher has identified eight new genomic regions that increase a person's risk for skin cancer. Researchers have discovered eight new loci -- locations on a person's genome -- that are susceptible to the development of squamous cell skin cancer.

CancerGroup.com